respirerx.jpg
RespireRx Pharmaceuticals Inc. Announces Publication of Ampakine Data:
25 juil. 2018 09h00 HE | RespireRX Pharmaceuticals Inc.
Effects of Chronic Systemic Low-impact Ampakine Treatment on Neurotrophin Expression in Rat Brain Glen Rock, N.J., July 25, 2018 (GLOBE NEWSWIRE) -- RespireRx Pharmaceuticals Inc. (OTCQB: RSPI)...
respirerx.jpg
RespireRx Pharmaceuticals Inc. Announces Resignation of Dr. James S. Manuso
19 juin 2018 16h14 HE | RespireRX Pharmaceuticals Inc.
Glen Rock, N.J, June 19, 2018 (GLOBE NEWSWIRE) -- RespireRx Pharmaceuticals Inc. announces the decision of Dr. James S. Manuso to resign as president, CEO, Vice Chairman and member of the Board of...
respirerx.jpg
Advancing Dronabinol Obstructive Sleep Apnea Program with Letter of Intent for Co-Development and Supply Agreement with Noramco, Inc.
19 juin 2018 08h45 HE | RespireRX Pharmaceuticals Inc.
Glen Rock, N.J., June 19, 2018 (GLOBE NEWSWIRE) -- RespireRx Pharmaceuticals Inc. (OTCQB: RSPI) (“RespireRx” or the “Company”), is pleased to announce that on June 13, 2018, it entered into a letter...
respirerx.jpg
RespireRx Pharmaceuticals Inc. Officers and Directors Elect to Forgive $2,356,733 of Past Due Cash Compensation and Receive Non-Qualified Stock Options to Reduce Balance Sheet Debt
15 déc. 2017 09h00 HE | RespireRX Pharmaceuticals Inc.
Glen Rock, N.J., Dec. 15, 2017 (GLOBE NEWSWIRE) -- RespireRx Pharmaceuticals Inc. (OTC QB: RSPI) (“RespireRx” or the “Company”), a leader in the development of medicines for the treatment of...
Akers Bio logo
Financial Results for First Quarter 2015
14 mai 2015 07h00 HE | Akers Biosciences Inc.
THOROFARE, N.J., May 14, 2015 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (Nasdaq:AKER) (AIM:AKR.L) (the "Company" or "Akers Bio"), a medical device company focused on reducing the cost of healthcare...
Cortex
Cortex Pharmaceuticals, Inc. Announces Publication of Research Results on the Use of Ampakines CX1739 and CX717 in the Treatment of Respiratory Disorders
04 mai 2015 09h00 HE | Cortex Pharmaceuticals, Inc.
GLEN ROCK, N.J., May 4, 2015 (GLOBE NEWSWIRE) -- Cortex Pharmaceuticals, Inc. (OTC:CORX) ("Cortex" or the "Company") announces the recent publication of two key scientific papers co-authored by the...